Novacyt (NCYT) Competitors GBX 40.25 -0.16 (-0.41%) As of 07:32 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock NCYT vs. CREO, IUG, IHC, AVO, RUA, POLX, SUN, MHC, BELL, and MXCTShould you be buying Novacyt stock or one of its competitors? The main competitors of Novacyt include Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Polarean Imaging (POLX), Surgical Innovations Group (SUN), MyHealthChecked (MHC), Belluscura (BELL), and MaxCyte (MXCT). These companies are all part of the "medical devices" industry. Novacyt vs. Its Competitors Creo Medical Group Intelligent Ultrasound Group Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences Polarean Imaging Surgical Innovations Group MyHealthChecked Belluscura MaxCyte Creo Medical Group (LON:CREO) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings. Which has more risk & volatility, CREO or NCYT? Creo Medical Group has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Novacyt has a beta of -1.86, indicating that its stock price is 286% less volatile than the S&P 500. Do institutionals & insiders have more ownership in CREO or NCYT? 45.1% of Creo Medical Group shares are held by institutional investors. Comparatively, 10.7% of Novacyt shares are held by institutional investors. 4.1% of Creo Medical Group shares are held by company insiders. Comparatively, 0.4% of Novacyt shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is CREO or NCYT more profitable? Creo Medical Group has a net margin of -73.93% compared to Novacyt's net margin of -203.06%. Creo Medical Group's return on equity of -41.79% beat Novacyt's return on equity.Company Net Margins Return on Equity Return on Assets Creo Medical Group-73.93% -41.79% -20.09% Novacyt -203.06%-47.73%-27.98% Which has higher earnings and valuation, CREO or NCYT? Creo Medical Group has higher earnings, but lower revenue than Novacyt. Creo Medical Group is trading at a lower price-to-earnings ratio than Novacyt, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreo Medical Group£4.60M10.54-£25.04M-£0.01-1,175.00Novacyt£19.63M1.45-£36.80M-£0.59-68.22 Does the media refer more to CREO or NCYT? In the previous week, Novacyt had 2 more articles in the media than Creo Medical Group. MarketBeat recorded 2 mentions for Novacyt and 0 mentions for Creo Medical Group. Creo Medical Group's average media sentiment score of 0.00 beat Novacyt's score of -0.14 indicating that Creo Medical Group is being referred to more favorably in the media. Company Overall Sentiment Creo Medical Group Neutral Novacyt Neutral SummaryCreo Medical Group beats Novacyt on 10 of the 13 factors compared between the two stocks. Get Novacyt News Delivered to You Automatically Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NCYT vs. The Competition Export to ExcelMetricNovacytMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£28.43M£2.56B£6.11B£2.61BDividend YieldN/A2.44%5.66%5.29%P/E Ratio-68.22199.1486.814,482.79Price / Sales1.45137.89538.9799,701.31Price / Cash0.5815.9926.3027.90Price / Book0.403.8012.678.18Net Income-£36.80M£132.05M£3.30B£5.89B7 Day Performance-4.16%2.57%3.55%1.16%1 Month Performance4.01%1.15%6.79%6.41%1 Year Performance-34.23%12.42%72.30%154.01% Novacyt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NCYTNovacytN/AGBX 40.25-0.4%N/A-34.0%£28.43M£19.63M-68.22120Earnings ReportCREOCreo Medical GroupN/AGBX 11.75+1.1%N/A-46.0%£48.47M£4.60M-146.88279Gap DownIUGIntelligent Ultrasound GroupN/AN/AN/AN/A£42.76M£6.57M-18.9165IHCInspiration Healthcare GroupN/AGBX 21.25-1.2%N/A+14.9%£19.05M£38.25M-112.91224AVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.20-2.6%N/A-20.5%£6.95M£4.11M-2.6148Gap DownPOLXPolarean ImagingN/AGBX 0.48flatN/A-66.5%£5.73M£2.56M-43.1828News CoverageGap DownSUNSurgical Innovations GroupN/AGBX 0.57-0.7%N/A+3.8%£5.33M£11.95M-271.9080Gap UpMHCMyHealthCheckedN/AGBX 10.01-4.7%N/A-24.4%£5.21M£3.61M-290.1716Gap DownBELLBelluscuraN/AGBX 0.75flatN/AN/A£3.01M£1.80M-5.7324MXCTMaxCyteN/AGBX 1.60+1.3%N/A-99.4%£1.70M£35.75M-4.0080High Trading Volume Related Companies and Tools Related Companies Creo Medical Group Alternatives Intelligent Ultrasound Group Alternatives Inspiration Healthcare Group Alternatives Advanced Oncotherapy Alternatives RUA Life Sciences Alternatives Polarean Imaging Alternatives Surgical Innovations Group Alternatives MyHealthChecked Alternatives Belluscura Alternatives MaxCyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:NCYT) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novacyt S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novacyt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
